These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 3466239)

  • 21. Recombinant DNA: international guidelines.
    Miller HI; Young FE
    Science; 1987 Jan; 235(4784):14. PubMed ID: 3798092
    [No Abstract]   [Full Text] [Related]  

  • 22. The biotechnology revolution and its regulatory evolution.
    Hoffman DE
    Drake Law Rev; 1988-1989; 38(3):471-550. PubMed ID: 16086466
    [No Abstract]   [Full Text] [Related]  

  • 23. Testimony of the American Society for Medical Technology before the Center for Disease Control's Public Hearing on proposed personnel standards.
    Price GD
    Am J Med Technol; 1980 Aug; 46(8):597-602. PubMed ID: 6252778
    [No Abstract]   [Full Text] [Related]  

  • 24. Congressional hearing on the environmental implications of genetic engineering.
    Milewski E
    Recomb DNA Tech Bull; 1983 Sep; 6(3):103-10. PubMed ID: 6579582
    [No Abstract]   [Full Text] [Related]  

  • 25. The National Institutes of Health system for enhancing the science, safety, and ethics of recombinant DNA research.
    Shipp AC; Patterson AP
    Comp Med; 2003 Apr; 53(2):159-64. PubMed ID: 12784849
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The attitudes of religious, environmental, and science policy leaders toward biotechnology.
    Miller JD
    Recomb DNA Tech Bull; 1985 Dec; 8(4):141-64. PubMed ID: 4095277
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Testimony before the senate A/Testimony before the Senate Subcommittee on Government Research of the Committee on Government Operations. Ninetieth Congress, first session, S. 836: a bill to create a National Foundation for the Social Sciences.
    Am Psychol; 1967 Nov; 22(11):915-69. PubMed ID: 6075375
    [No Abstract]   [Full Text] [Related]  

  • 28. USDA research rules killed; NIH panel to rewrite standards.
    Crawford M
    Science; 1986 Nov; 234(4777):668. PubMed ID: 3775360
    [No Abstract]   [Full Text] [Related]  

  • 29. The regulation of biotechnology products as "toxics".
    Shanks PL; Gibbons SL
    Healthspan; 1985 Feb; 2(2):21-8. PubMed ID: 10289625
    [No Abstract]   [Full Text] [Related]  

  • 30. Administration hints at clampdown on biotechnology exports.
    Budiansky S; David P
    Nature; 1984 May 31-Jun 6; 309(5967):389. PubMed ID: 6587188
    [No Abstract]   [Full Text] [Related]  

  • 31. Testimony before the Senate Subcommittee on Government Research of the Committee on Government Operations. Ninetieth Congress, first session, S. 843. Full Opportunity and Social Accounting Act.
    Am Psychol; 1967 Nov; 22(11):977-1035. PubMed ID: 6080712
    [No Abstract]   [Full Text] [Related]  

  • 32. The brave new world of animal biotechnology. Project report.
    Donnelley S; McCarthy CR; Singleton R
    Hastings Cent Rep; 1994; 24(1 Suppl):S1-31. PubMed ID: 11654088
    [No Abstract]   [Full Text] [Related]  

  • 33. Models of genetically engineered organisms and their ecological impact.
    Regal PJ
    Recomb DNA Tech Bull; 1987 Sep; 10(3):67-85. PubMed ID: 3317526
    [No Abstract]   [Full Text] [Related]  

  • 34. Testimony of George E. Hardy, Jr., M. D., M. P. H. Health Officer, Jefferson County Department of Health. Before the House Subcommittee on Public Health and Environment of the House Committee on Interstate and Foreign Commerce, U. S. House of Representatives, Washington, D. C. on Thursday, April 27, 1972.
    Hardy GE
    J Med Assoc State Ala; 1972 Jul; 42(1):12 passim. PubMed ID: 5044794
    [No Abstract]   [Full Text] [Related]  

  • 35. Opening statement: Joint hearing on federal coordination policy for biotechnology, July 23, 1986.
    Walgren D
    Recomb DNA Tech Bull; 1986 Sep; 9(3):137-8. PubMed ID: 3786827
    [No Abstract]   [Full Text] [Related]  

  • 36. Regulation of Agrobacterium gene manipulation.
    Dewhurst F
    Methods Mol Biol; 1995; 44():369-91. PubMed ID: 7581679
    [No Abstract]   [Full Text] [Related]  

  • 37. Testimony of the American Federation for Clinical Research before the US Senate Labor-HHS-Education Appropriations Subcommittee and the US House of Representatives Appropriations Subcommittee concerning NIH support in FY 1985.
    Schwartz BD; Fox IJ
    Clin Res; 1984 Sep; 32(3):362-3. PubMed ID: 6488701
    [No Abstract]   [Full Text] [Related]  

  • 38. Testimony at congressional hearing on biotechnology--July 23, 1986.
    Recomb DNA Tech Bull; 1986 Sep; 9(3):133-210. PubMed ID: 3786825
    [No Abstract]   [Full Text] [Related]  

  • 39. Regulation of products from biotechnology.
    Sharples FE
    Science; 1987 Mar; 235(4794):1329-32. PubMed ID: 3823888
    [No Abstract]   [Full Text] [Related]  

  • 40. US regulatory system for genetically modified [genetically modified organism (GMO), rDNA or transgenic] crop cultivars.
    McHughen A; Smyth S
    Plant Biotechnol J; 2008 Jan; 6(1):2-12. PubMed ID: 17956539
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.